KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Deffered Revenue (2016 - 2025)

Novavax has reported Non-Current Deffered Revenue over the past 16 years, most recently at $358.9 million for Q4 2025.

  • Quarterly results put Non-Current Deffered Revenue at $358.9 million for Q4 2025, down 19.67% from a year ago — trailing twelve months through Dec 2025 was $358.9 million (down 19.67% YoY), and the annual figure for FY2025 was $358.9 million, down 19.67%.
  • Non-Current Deffered Revenue for Q4 2025 was $358.9 million at Novavax, down from $397.1 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for NVAX hit a ceiling of $1.0 billion in Q3 2022 and a floor of $172.5 million in Q4 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $446.8 million (2024), compared with a mean of $507.2 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: skyrocketed 246.83% in 2023 and later crashed 51.33% in 2025.
  • Novavax's Non-Current Deffered Revenue stood at $172.5 million in 2021, then grew by 4.0% to $179.4 million in 2022, then skyrocketed by 246.83% to $622.2 million in 2023, then dropped by 28.19% to $446.8 million in 2024, then decreased by 19.67% to $358.9 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $358.9 million (Q4 2025), $397.1 million (Q3 2025), and $399.3 million (Q2 2025) per Business Quant data.